Steven C. Quay, President & CEO at ATOSSA THERAPEUTICS, INC. (ATOS), bought 11,239 shares at $0.88 ($10K) on 2025-05-21, disclosed to the SEC on 2025-05-22.
Open-market purchase of $10k ATOS by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ATOS | BUY | 2016-01-21 | $10K | — | Filing → |
| ATOS | SELL | 2013-10-03 | $41K | — | Filing → |
| NSTK | SELL | 2007-09-28 | $71K | — | Filing → |